JP2014141526A5 - - Google Patents

Download PDF

Info

Publication number
JP2014141526A5
JP2014141526A5 JP2014089153A JP2014089153A JP2014141526A5 JP 2014141526 A5 JP2014141526 A5 JP 2014141526A5 JP 2014089153 A JP2014089153 A JP 2014089153A JP 2014089153 A JP2014089153 A JP 2014089153A JP 2014141526 A5 JP2014141526 A5 JP 2014141526A5
Authority
JP
Japan
Prior art keywords
hydrogen atom
bifidobacteria
glucosidase inhibitor
general formula
hypoglycemic effect
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014089153A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014141526A (ja
JP5932878B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2014089153A priority Critical patent/JP5932878B2/ja
Priority claimed from JP2014089153A external-priority patent/JP5932878B2/ja
Publication of JP2014141526A publication Critical patent/JP2014141526A/ja
Publication of JP2014141526A5 publication Critical patent/JP2014141526A5/ja
Application granted granted Critical
Publication of JP5932878B2 publication Critical patent/JP5932878B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014089153A 2009-03-26 2014-04-23 血糖降下作用増強剤 Active JP5932878B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014089153A JP5932878B2 (ja) 2009-03-26 2014-04-23 血糖降下作用増強剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2009077555 2009-03-26
JP2009077555 2009-03-26
JP2014089153A JP5932878B2 (ja) 2009-03-26 2014-04-23 血糖降下作用増強剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010069561A Division JP5536504B2 (ja) 2009-03-26 2010-03-25 血糖降下作用増強剤

Publications (3)

Publication Number Publication Date
JP2014141526A JP2014141526A (ja) 2014-08-07
JP2014141526A5 true JP2014141526A5 (OSRAM) 2015-04-30
JP5932878B2 JP5932878B2 (ja) 2016-06-08

Family

ID=42781065

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010069561A Active JP5536504B2 (ja) 2009-03-26 2010-03-25 血糖降下作用増強剤
JP2014089153A Active JP5932878B2 (ja) 2009-03-26 2014-04-23 血糖降下作用増強剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010069561A Active JP5536504B2 (ja) 2009-03-26 2010-03-25 血糖降下作用増強剤

Country Status (5)

Country Link
US (1) US8889375B2 (OSRAM)
JP (2) JP5536504B2 (OSRAM)
MY (1) MY176503A (OSRAM)
SG (2) SG174540A1 (OSRAM)
WO (1) WO2010110374A1 (OSRAM)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5769710B2 (ja) * 2010-07-22 2015-08-26 ビオフェルミン製薬株式会社 脂質代謝改善剤、脂質代謝改善作用増強剤、抗肥満剤及び抗肥満作用増強剤
JP5681533B2 (ja) * 2011-03-14 2015-03-11 ビオフェルミン製薬株式会社 消化管痛の予防又は軽減剤
JP6983407B2 (ja) * 2015-07-07 2021-12-17 東亜薬品工業株式会社 菌含有口腔内速崩壊性錠剤
KR101697260B1 (ko) * 2015-07-27 2017-01-17 고려대학교 산학협력단 보글리보즈를 유효성분으로 함유하는 비만 개선, 정장 또는 장내 균총 개선용 조성물
JP6637725B2 (ja) * 2015-10-28 2020-01-29 ビオフェルミン製薬株式会社 ウイルス感染症の予防及び/又は治療剤
EP3508068A4 (en) 2016-09-02 2019-10-09 FUJIFILM Corporation LIVESTOCK OR FODDER SUPPLEMENT, GROWTH CONVEYOR FOR LACTOBACILLUS BACTERIA AND METHOD FOR THE GROWTH PROMOTION OF LACTOBACILLUS BACTERIA
JP7235270B2 (ja) * 2018-02-09 2023-03-08 エースバイオプロダクト株式会社 血糖値上昇抑制剤及び同血糖値上昇抑制剤の製造方法
WO2020142698A1 (en) * 2019-01-05 2020-07-09 Foremost Technologies and Products, Inc. High pressure processing of foods and supplements
CN111748000B (zh) * 2019-03-29 2022-05-20 沈阳药科大学 3-脱氧-5-羟基-1-氨基碳糖类化合物及其用途
JP2020184909A (ja) * 2019-05-13 2020-11-19 学校法人帝京大学 血糖降下剤、及び、該血糖降下剤を含有する飲食品
CN112386612A (zh) * 2020-12-01 2021-02-23 贾卫国 一种用于预防糖尿病的益生菌生物制剂及其制备工艺
WO2022187361A1 (en) * 2021-03-03 2022-09-09 Emergent Product Development Gaithersburg Inc. Valiolamine derivatives as glucosidase inhibitors
CN118620807B (zh) * 2024-08-15 2024-10-22 山东健源生物科技有限公司 一株具有减肥、降血糖作用的乳酸片球菌及其后生元和应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0194794A3 (en) * 1985-03-08 1986-12-17 Takeda Chemical Industries, Ltd. Saccharide digestion inhibiting composition
ZA927277B (en) 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
JPH08298982A (ja) * 1995-05-02 1996-11-19 Aasu Giken:Kk 複合微生物製剤
JPH107577A (ja) 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
JP2004113068A (ja) * 2002-09-25 2004-04-15 Sanwa Kosan Kk 腸内ビフィズス菌増殖促進剤
US7108869B2 (en) * 2002-11-07 2006-09-19 Access Business Group International Llc Nutritional supplement containing alpha-glucosidase and alpha-amylase inhibitors
JP2004357505A (ja) * 2003-05-30 2004-12-24 Fancl Corp 胃腸疾患予防・軽減のための犬用サプリメント
JP4463525B2 (ja) * 2003-10-23 2010-05-19 ビオフェルミン製薬株式会社 減感作療法用剤
JP2006020581A (ja) * 2004-07-08 2006-01-26 Cdom:Kk ペット用食品及びその製造方法
JP2006020606A (ja) 2004-07-09 2006-01-26 Someya Hideo 肥満防止、改善のための健康食品用組成物
JP2006055116A (ja) * 2004-08-23 2006-03-02 Michiyo Miura α−グルコシダーゼ活性阻害食品
CA2655665A1 (en) 2006-05-26 2007-12-06 Nestec S.A. Methods of use and nutritional compositions of touchi extract
JP2007330124A (ja) 2006-06-13 2007-12-27 Kenko Tsusho Kk 肥満及び生活習慣病の防止・改善をする為の健康食品用組成物
JP4990297B2 (ja) * 2007-02-01 2012-08-01 株式会社Tkバイオ研究所 ブドウ果皮・種子乳酸菌発酵物及びそれを利用した医薬
JP2008222701A (ja) * 2007-03-09 2008-09-25 Kangwon National Univ Industry Cooperation Foundation 肥満予防及び治療用発酵物、糖尿病予防用発酵物、肥満予防及び治療用発酵食品および糖尿病予防用食品

Similar Documents

Publication Publication Date Title
JP2014141526A5 (OSRAM)
MY160542A (en) An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase
JP2012140436A5 (ja) 物質
EA201290260A1 (ru) Бензимидазол-имидазольные производные
JP2016503799A5 (OSRAM)
MY189770A (en) Biaryl derivative as gpr120 agonists
BR112012025167A2 (pt) modificador de sabor doce
SA112330774B1 (ar) معدِّل نكهة حُلوة
EA201390934A1 (ru) Композиции и способы модулирования fxr
EA201100136A1 (ru) 2,4'-бипиридинилы в качестве ингибиторов протеинкиназы d, применимые для лечения сердечной недостаточности и рака
CN108026053A8 (zh) 作为mIDH1抑制剂的稠合的咪唑类化合物
BR112013031144A2 (pt) produto modificador de sabor
WO2012089828A3 (en) Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
EA201070477A1 (ru) Транс-кломифен для лечения метаболического синдрома
WO2016025933A3 (en) Substituted polycyclic antibacterial compounds
WO2009153178A3 (en) Aryl ketone as mri
JP2016520133A5 (OSRAM)
JP2013537240A5 (OSRAM)
MY192545A (en) Crystalline fumarate salt of (s)-[3,4-difluoro-2-(2-fluoro-4-iodophenylamino)phenyl] [3-hydroxy-3-(piperidin-2-yl) azetidin-1-yl]-methanone
JP2011016798A5 (OSRAM)
MX2016001095A (es) Sales de dasatinib en forma cristalina.
WO2012145520A3 (en) Carbon monoxide releasing molecules and uses thereof
JP2011006409A5 (OSRAM)
RU2015155032A (ru) Тилозиновые производные и способ их получения
JP2011245846A5 (OSRAM)